Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2026-01-08 00:00:00 ET · period of report 2026-01-06 · accession 0000875320-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-08 | 2026-01-06 | VRTX | WAGNER CHARLES F JR | EVP, CO, FO | M - OptEx | $189.38 | +9,532 | 47.3K | +25% | +$1.81M |
| D | 2026-01-08 | 2026-01-06 | VRTX | WAGNER CHARLES F JR | EVP, CO, FO | S - Sale+OE | $461.00 | -9,532 | 37.7K | -20% | -$4.39M |
| D | 2026-01-08 | 2026-01-06 | VRTX | WAGNER CHARLES F JR | EVP, CO, FO | M - OptEx | $0.00 | -9,532 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-06 | M | A | 9,532 | $189.38 | 47,257 | D | — | — | |
| 2 | Common | Common Stock | 2026-01-06 | S | D | 9,532 | $461.00 | 37,725 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2026-01-06 | M | D | 9,532 | $0.00 | 0 | D | $189.38 · — to 2029-04-09 | 9,532 Common Stock | (F2) Fully vested. |